(4'-Cyano-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-methyl-carbamic acid tert-butyl ester, 250mg

(S)-Phenyl(4-(trifluoromethyl)phenyl)methanamine hydrochloride, 97%, 100mg

Azure C (C.I. 52002), 25 g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine, 95.0%, 250mg

(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine, 95.0%, 10g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 1g

1-[4-(5-Amino-1H-pyrazol-1-yl)piperidin-1-yl]ethan-1-one, 1g

2,6-Dichlorotoluene>99.0%(GC)100g

2-Cyclopropyloxazole-5-carboxylic acid, 97%, 5g

5-(3-Chloro-6-methylphenyl)-5-oxovaleric acid, 97.0%, 1g

3-Bromo-4-chlorobenzenesulfonamide, 100mg

9-Oxoxanthene-2-carboxylic acid, 95.0%, 250mg

ethyl 4-(trifluoromethyl)-1H-pyrazole-5-carboxylate, 98%, 1g